Which of the following clients may be eligible for hospital-based, disease-specific case management support? (Select all that apply.)
a. Those who have high-cost conditions
b. Those with physicians who request such intervention for their patients
c. Those who may be maintained in a stable condition in their home environment
d. Those who have access to private insurance plans
e. Those who have requested such services
f.
Those whose hospital has a collaborative agreement with a home health nursing agency
ANS: A, C
Case management services are often provided for individuals who are identified as having medical conditions that are high-cost or high-volume acute and chronic illnesses such as congestive heart failure. The goal is to keep these clients as healthy as possible and stable in their home environment. Doing so will decrease the frequency and length of hospital stays and therefore decrease health care costs.
You might also like to view...
The charge nurse is supervising the care of four critical care patients being monitored using invasive hemodynamic modalities. Which patient should the charge nurse evaluate first?
a. A patient in cardiogenic shock with a cardiac output (CO) of 2.0 L/min b. A patient with a pulmonary artery systolic pressure (PAP) of 20 mm Hg c. A hypovolemic patient with a central venous pressure (CVP) of 6 mm Hg d. A patient with a pulmonary artery occlusion pressure (PAOP) of 10 mm Hg
What does the nurse, working in a community health clinic, teach about disease prevention?
A) That it is best achieved through attending self-help groups B) That it is best achieved by taking yearly physicals C) That it is best achieved by being an active participant in the community D) That it is best achieved by exhibiting behaviors that promote health
In glomerulonephritis, what damages the epithelial cells resulting in proteinuria?
a. Ischemia b. Lysosomal enzymes c. Compression from edema d. Activated complement e. Altered membrane permeability
The primary mechanism of action of nitrogen mustard class of anti-cancer drugs is the inhibition of
A. DNA synthesis. B. RNA. synthesis: C. Protein synthesis. D. mitosis E. folic acid synthesis.